The Business of Medical Writing: Communication, Leadership, and Corporate Responsibility

Part 2 in a 3-Part Series

Authors

  • Joan Affleck, MBA Merck & Co, Inc, Rahway, NJ
  • Dominic De Bellis, PhD Merck & Co, Inc, Rahway, NJ
  • Brian Bass, MWC Bass Global, Inc, Fort Myers, FL
  • Jeanette M. Towles, MA, RAC-Drugs Synterex, Inc, Dedham, MA

DOI:

https://doi.org/10.55752/amwa.2023.273

Abstract

A high-performing medical writing team begins and ends with talented writers, editors, and leaders who understand their mission and their business. A panel of writers comprising the authors convened virtually on October 28, 2021, at the American Medical Writers Association National Conference to discuss this topic. The topics of value proposition and business models; communication, leadership, and corporate responsibility; and financial acumen will be reprised in this 3-part series. The series will also include thoughts from the authors looking to the future of the business of medical writing, including what we can do in the medical writing community to introduce these concepts earlier in the medical writing career path. This Part 2 manuscript focuses on communication, leadership, and corporate responsibility.

Published

2023-12-12

How to Cite

1.
Affleck J, De Bellis D, Bass B, Towles J. The Business of Medical Writing: Communication, Leadership, and Corporate Responsibility: Part 2 in a 3-Part Series. AMWA. 2023;38(4). doi:10.55752/amwa.2023.273